Market Value1,688,544,000
Total Holdings70
File Date2021-11-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CYTK / Cytokinetics, Incorporated
ICPT / Intercept Pharmaceuticals Inc Call
ZTS / Zoetis Inc.
JNCE / Jounce Therapeutics Inc
KDMN / Kadmon Holdings Inc
REGN / Regeneron Pharmaceuticals, Inc. Put
CCXI / ChemoCentryx Inc
CCXI / ChemoCentryx Inc Call
FATE / Fate Therapeutics, Inc.
TCRR / Tcr2 Therapeutics Inc
AVTE / Aerovate Therapeutics, Inc.
ZYME / Zymeworks Inc.
BPMC / Blueprint Medicines Corporation
KURA / Kura Oncology, Inc.
TCRR / Tcr2 Therapeutics Inc Put
OBSV / ObsEva SA.
HZNP / Horizon Therapeutics Plc
CHRS / Coherus Oncology, Inc.
REPL / Replimune Group, Inc.
PTCT / PTC Therapeutics, Inc.
SVRA / Savara Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
ACAD / ACADIA Pharmaceuticals Inc. Call
ALXO / ALX Oncology Holdings Inc.
ARK ETF TR / Genomic Rev ETF Put (00214Q952)
MGNX / MacroGenics, Inc.
OEF / iShares Trust - iShares S&P 100 ETF Put
ALGS / Aligos Therapeutics, Inc.
PDSB / PDS Biotechnology Corporation
AKUS / Akouos Inc
BMYMP / Bristol-Myers Squibb Company - Preferred Security Call
OTIC / Otonomy Inc
NVCR / NovoCure Limited Call
XLRN / Acceleron Pharma Inc
14161H108 / Cardtronics PLC
AGIO / Agios Pharmaceuticals, Inc.
AMGN / Amgen Inc.
NBIX / Neurocrine Biosciences, Inc.
CMPI / Checkmate Pharmaceuticals Inc
FUSN / Fusion Pharmaceuticals Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
PODD / Insulet Corporation
CCXI / ChemoCentryx Inc Put
UTHR / United Therapeutics Corporation
ITCI / Intra-Cellular Therapies, Inc.
CYT / Cyteir Therapeutics, Inc.
SRRA / Sierra Oncology Inc
ALGN / Align Technology, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
HRTX / Heron Therapeutics, Inc.
GH / Guardant Health, Inc.
PTGX / Protagonist Therapeutics, Inc.
PTGX / Protagonist Therapeutics, Inc. Call
ISEE / IVERIC bio Inc Put
KRTX / Karuna Therapeutics, Inc.
BIIB / Biogen Inc.
RETA / Reata Pharmaceuticals Inc - Class A
RGNX / REGENXBIO Inc.
MRTX / Mirati Therapeutics, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
UTHR / United Therapeutics Corporation Put
DXCM / DexCom, Inc.
MRK / Merck & Co., Inc. Call
TVTX / Travere Therapeutics, Inc.
ABBV / AbbVie Inc.
CTIC / CTI BioPharma Corp
FGEN / FibroGen, Inc. Put
SNDX / Syndax Pharmaceuticals, Inc.
IMTX / Immatics N.V.
ISEE / IVERIC bio Inc
NXTC / NextCure, Inc.
GRTX / Galera Therapeutics, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
FULC / Fulcrum Therapeutics, Inc.
NCNA / NuCana plc - Depositary Receipt (Common Stock)
EXEL / Exelixis, Inc.
SYBX / Synlogic, Inc.
CLDX / Celldex Therapeutics, Inc.
AGEN / Agenus Inc.
INZY / Inozyme Pharma, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
BOLT / Bolt Biotherapeutics, Inc.
QURE / uniQure N.V.
NTRA / Natera, Inc.
SRPT / Sarepta Therapeutics, Inc.
INSM / Insmed Incorporated
VERA / Vera Therapeutics, Inc.
MRNS / Marinus Pharmaceuticals, Inc.